WNT1 and osteogenesis imperfecta: We investigated the impacts of the variants on WNT1 activities and applied human proteomic and single-cell transcriptome to further explore the differentiation trajectory of osteogenic progenitors and the downstream pathways regulated by WNT1, aiming to uncover the pathogenic mechanisms of type XV OI and provide a new direction for the treatment strategy.